These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4053491)

  • 21. [In vitro comparative bactericidal effect of cefotaxime and cefixime in a kinetic model].
    Rolin O; Roche G; Bouanchaud DH
    Presse Med; 1989 Oct; 18(32):1569-71. PubMed ID: 2530534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime, in the dog.
    Bialer M; Batra VK; Morrison JA; Silber BM; Look ZM; Yacobi A
    Pharm Res; 1987 Feb; 4(1):33-7. PubMed ID: 3508527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetics and serum and urine bactericidal activity of ciprofloxacin.
    Brittain DC; Scully BE; McElrath MJ; Steinman R; Labthavikul P; Neu HC
    J Clin Pharmacol; 1985 Mar; 25(2):82-8. PubMed ID: 3157705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative activity of cefixime and cefaclor in an in vitro model simulating human pharmacokinetics.
    Nies BA
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):558-61. PubMed ID: 2504600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacology of cefixime in unweaned calves.
    Ziv G; Lavy E; Glickman A; Winkler M
    J Vet Pharmacol Ther; 1995 Apr; 18(2):94-100. PubMed ID: 7629935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
    Jones RN; Barry AL
    Chemioterapia; 1988 Oct; 7(5):283-6. PubMed ID: 3147148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential.
    Brogden RN; Campoli-Richards DM
    Drugs; 1989 Oct; 38(4):524-50. PubMed ID: 2684593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical evaluation of cefixime in children].
    Meguro H; Arimasu O; Sohda H; Yoshida J; Togasaki K; Fujii R
    Jpn J Antibiot; 1986 Apr; 39(4):1007-19. PubMed ID: 3761534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cefixime. Microbiologic, kinetic and clinical profile].
    Di Nola F; Arione R; Bramato C
    Minerva Med; 1991 Oct; 82(10):633-56. PubMed ID: 1745375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of cefixime, a new oral cephalosporin.
    Nakashima M; Uematsu T; Takiguchi Y; Kanamaru M
    J Clin Pharmacol; 1987; 27(5):425-31. PubMed ID: 3693588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].
    Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H
    Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic parameters and killing rates in serum of volunteers receiving amoxicillin, cefadroxil or cefixime alone or associated with niflumic acid or paracetamol.
    Carsenti-Etesse H; Farinotti R; Durant J; Roger PM; De Salvador F; Bernard E; Rouveix B; Dellamonica P
    Eur J Drug Metab Pharmacokinet; 1998; 23(3):357-66. PubMed ID: 9842977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fundamental and clinical studies on cefixime in pediatric field].
    Miyazaki M; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1986 Apr; 39(4):1166-75. PubMed ID: 3761545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
    Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
    Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency.
    Guay DR; Meatherall RC; Harding GK; Brown GR
    Antimicrob Agents Chemother; 1986 Sep; 30(3):485-90. PubMed ID: 3777912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic profile of cefixime in man.
    Faulkner RD; Yacobi A; Barone JS; Kaplan SA; Silber BM
    Pediatr Infect Dis J; 1987 Oct; 6(10):963-70. PubMed ID: 3696837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical study on cefixime granules in the field of pediatrics].
    Haruta T; Kuroki S; Kobayashi Y
    Jpn J Antibiot; 1986 Apr; 39(4):1106-14. PubMed ID: 3761540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefixime shows good effects on group A and group B beta-haemolytic streptococci.
    Liberto MC; Carbone M; Fera MT; Berlinghieri MC; Puccio R; Focà A; De Luca M; Casini A
    Drugs Exp Clin Res; 1991; 17(6):305-8. PubMed ID: 1769318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fundamental and clinical studies on cefixime in pediatrics].
    Kurashige T; Morita H; Araki K; Ogura H; Morioka N; Kitamura I
    Jpn J Antibiot; 1986 Apr; 39(4):1157-65. PubMed ID: 3761544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overview of the clinical features of cefixime.
    Adam D
    Chemotherapy; 1998 Sep; 44 Suppl 1():1-5. PubMed ID: 9797415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.